Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials

ConclusionWe proposed a new prognosis model for TEND MM patients at diagnosis based on two RSF approaches.Trial registrationIMAJEM: NCT01309334 and EMN02/HO95: NCT01134484

Source: European Journal of Nuclear Medicine and Molecular Imaging - October 1, 2020 Category: Nuclear Medicine Source Type: research